<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jats2jats3.xsl?><?ConverterInfo.Version 1?><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Acta Crystallogr F Struct Biol Commun</journal-id><journal-id journal-id-type="iso-abbrev">Acta Crystallogr F Struct Biol Commun</journal-id><journal-id journal-id-type="publisher-id">Acta Cryst. F</journal-id><journal-title-group><journal-title>Acta Crystallographica. Section F, Structural Biology Communications</journal-title></journal-title-group><issn pub-type="epub">2053-230X</issn><publisher><publisher-name>International Union of Crystallography</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">8725005</article-id><article-id pub-id-type="publisher-id">ft5115</article-id><article-id pub-id-type="doi">10.1107/S2053230X21012322</article-id><article-id pub-id-type="coden">ACSFEN</article-id><article-id pub-id-type="publisher-id">S2053230X21012322</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Communications</subject></subj-group></article-categories><title-group><article-title>The crystal structure of DynF from the dynemicin-biosynthesis pathway of <italic toggle="yes">Micromonospora chersina</italic>
</article-title><alt-title>DynF</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kosgei</surname><given-names>Abigael J.</given-names></name><xref rid="a" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-1626-4943</contrib-id><name><surname>Miller</surname><given-names>Mitchell D.</given-names></name><xref rid="a" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Bhardwaj</surname><given-names>Minakshi</given-names></name><xref rid="b" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name><surname>Xu</surname><given-names>Weijun</given-names></name><xref rid="a" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-7148-0721</contrib-id><name><surname>Thorson</surname><given-names>Jon S.</given-names></name><xref rid="b" ref-type="aff">b</xref><xref rid="c" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name><surname>Van Lanen</surname><given-names>Steven G.</given-names></name><xref rid="a" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-4171-4603</contrib-id><name><surname>Phillips</surname><given-names>George N.</given-names><suffix>Jr</suffix></name><xref rid="a" ref-type="aff">a</xref><xref rid="d" ref-type="aff">d</xref><xref rid="cor" ref-type="corresp">*</xref></contrib><aff id="a">
<label>a</label>Department of Biosciences, <institution>Rice University</institution>, Houston, TX 77251, <country>USA</country>
</aff><aff id="b">
<label>b</label>Department of Pharmaceutical Sciences, College of Pharmacy, <institution>University of Kentucky</institution>, Lexington, KY 40506, <country>USA</country>
</aff><aff id="c">
<label>c</label>Center for Pharmaceutical Research and Innovation, College of Pharmacy, <institution>University of Kentucky</institution>, Lexington, KY 40506, <country>USA</country>
</aff><aff id="d">
<label>d</label>Department of Chemistry, <institution>Rice University</institution>, Houston, TX 77251, <country>USA</country>
</aff></contrib-group><author-notes><corresp id="cor">Correspondence e-mail: <email>georgep@rice.edu</email>
</corresp></author-notes><pub-date pub-type="collection"><day>01</day><month>1</month><year>2022</year></pub-date><pub-date pub-type="epub"><day>01</day><month>1</month><year>2022</year></pub-date><pub-date pub-type="pmc-release"><day>01</day><month>1</month><year>2022</year></pub-date><!--PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>.--><volume>78</volume><issue>Pt 1</issue><issue-id pub-id-type="publisher-id">f220100</issue-id><fpage>1</fpage><lpage>7</lpage><history><date date-type="received"><day>15</day><month>9</month><year>2021</year></date><date date-type="accepted"><day>21</day><month>11</month><year>2021</year></date></history><permissions><copyright-statement>&#x000a9; Abigael J. Kosgei et al. 2022</copyright-statement><copyright-year>2022</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the
terms of the Creative Commons Attribution (CC-BY) Licence,
which permits unrestricted use, distribution, and
reproduction in any medium, provided the original authors and
source are cited.</license-p></license><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://doi.org/10.1107/S2053230X21012322">A full version of this article is
available from Crystallography Journals Online.</self-uri><abstract abstract-type="toc"><p>The crystal structure of DynF was determined to a resolution of 1.50&#x02005;&#x000c5;, revealing a dimeric eight-stranded &#x003b2;-barrel structure with palmitic acid bound in the interior.</p></abstract><abstract><p>Dynemicin is an enediyne natural product from <italic toggle="yes">Micromonospora chersina</italic> ATCC53710. Access to the biosynthetic gene cluster of dynemicin has enabled the <italic toggle="yes">in vitro</italic> study of gene products within the cluster to decipher their roles in assembling this unique molecule. This paper reports the crystal structure of DynF, the gene product of one of the genes within the biosynthetic gene cluster of dynemicin. DynF is revealed to be a dimeric eight-stranded &#x003b2;-barrel structure with palmitic acid bound within a cavity. The presence of palmitic acid suggests that DynF may be involved in binding the precursor polyene heptaene, which is central to the synthesis of the ten-membered ring of the enediyne core.</p></abstract><kwd-group><kwd>dynemicin</kwd><kwd>natural products</kwd><kwd>biosynthetic gene clusters</kwd><kwd>enediynes</kwd><kwd>poly&#x000ad;ketides</kwd><kwd>anthraquinone</kwd><kwd>&#x003b2;-barrel</kwd><kwd>unknown function</kwd><kwd>
<italic toggle="yes">Micromonospora chersina</italic> ATCC53710</kwd></kwd-group><funding-group><award-group><funding-source>National Institutes of Health, National Institute of General Medical Sciences</funding-source><award-id>RO1 GM115261</award-id><principal-award-recipient>Jon Thorson</principal-award-recipient><principal-award-recipient>George N. Phillips Jr. </principal-award-recipient></award-group><award-group><funding-source>National Institutes of Health, National Cancer Institute</funding-source><award-id>R01 CA217255 </award-id><principal-award-recipient>Jon Thorson</principal-award-recipient><principal-award-recipient>Steven Van Lanen</principal-award-recipient><principal-award-recipient>George N. Phillips Jr</principal-award-recipient></award-group><award-group><funding-source>National Science Foundation, BioXFEL Science and Technology Center</funding-source><award-id>1231306</award-id><principal-award-recipient>George N. Phillips Jr. </principal-award-recipient></award-group><funding-statement>This work was funded by <funding-source>National Institutes of Health, National Institute of General Medical Sciences</funding-source> grant <award-id>RO1 GM115261</award-id> to Jon Thorson and George N. Phillips Jr. ; <funding-source>National Institutes of Health, National Cancer Institute</funding-source> grant <award-id>R01 CA217255 </award-id> to Jon Thorson, Steven Van Lanen, and George N. Phillips Jr; <funding-source>National Science Foundation, BioXFEL Science and Technology Center</funding-source> grant <award-id>1231306</award-id> to George N. Phillips Jr. .</funding-statement></funding-group><counts><page-count count="7"/></counts></article-meta></front><body><sec sec-type="introduction" id="sec1"><label>1.</label><title>Introduction</title><p>Dynemicin A is an anthraquinone-fused ten-membered enediyne and a metabolite of <italic toggle="yes">Micromonospora chersina</italic> ATCC53710. Like many other enediynes, dynemicin has a novel molecular architecture, a notable mode of action and potent cytotoxicity (Thorson <italic toggle="yes">et al.</italic>, 2000<xref rid="bb35" ref-type="bibr"> &#x025b8;</xref>; Van Lanen &#x00026; Shen, 2008<xref rid="bb36" ref-type="bibr"> &#x025b8;</xref>). Dynemicin comprises an enediyne core, which is common to all enediynes, and peripheral moieties (Fig. 1<xref rid="fig1" ref-type="fig"> &#x025b8;</xref>), which give the enediynes structural diversity. The main ring of the dynemicin core contains two acetylenic groups conjugated to a double bond in a ten-membered carbocyle. The enediyne core structural unit (termed the warhead) is central to the fundamental mechanism of action. The anthraquinone group on the peripheral moeity of dynemicin intercalates into the minor groove of DNA to confer binding specificity (Sugiura <italic toggle="yes">et al.</italic>, 1990<xref rid="bb34" ref-type="bibr"> &#x025b8;</xref>).</p><p>In the presence of NADPH or thiol, the quinone is reduced to hydroquinone, leading to opening of the epoxide (Avenda&#x000f1;o &#x00026; Men&#x000e9;ndez, 2015<xref rid="bb4" ref-type="bibr"> &#x025b8;</xref>), which triggers the activation of the enediyne core. Dynemicin then undergoes a Bergman cycloaromatization to form a reactive 1,4-dehydrobenzene bi&#x000ad;radical that is capable of abstracting H atoms from the DNA backbone, causing single- or double-stranded DNA scission. The high reactivity of enediynes with DNA makes them quite toxic. In natural environments, some microorganisms producing enediynes protect themselves from their cytotoxic action by a self-resistance mechanism that uses a self-sacrificing protein (Biggins <italic toggle="yes">et al.</italic>, 2003<xref rid="bb7" ref-type="bibr"> &#x025b8;</xref>; Elshahawi <italic toggle="yes">et al.</italic>, 2014<xref rid="bb11" ref-type="bibr"> &#x025b8;</xref>) or specialized ABC transporters to export the toxin (Beis &#x00026; Rebuffat, 2019<xref rid="bb5" ref-type="bibr"> &#x025b8;</xref>). In cancer therapy, the toxicity of enediynes has been exploited by conjugating the molecules to tumor-specific monoclonal antibodies in polymer-assisted delivery systems to prevent premature cytotoxic effects on other important cells in the body (Abe &#x00026; Otsuki, 2002<xref rid="bb1" ref-type="bibr"> &#x025b8;</xref>; Shah, 2017<xref rid="bb30" ref-type="bibr"> &#x025b8;</xref>).</p><p>Dynemicin can be produced by organic synthesis or in <italic toggle="yes">M.&#x000a0;chersina</italic>. The total chemical synthesis of enediynes is challenging, but has been achieved for dynemicin (Nicolaou <italic toggle="yes">et&#x000a0;al.</italic>, 1991<xref rid="bb26" ref-type="bibr"> &#x025b8;</xref>, 1993<xref rid="bb25" ref-type="bibr"> &#x025b8;</xref>; Shair <italic toggle="yes">et al.</italic>, 1996<xref rid="bb31" ref-type="bibr"> &#x025b8;</xref>; Myers <italic toggle="yes">et al.</italic>, 1995<xref rid="bb24" ref-type="bibr"> &#x025b8;</xref>). The cloning, sequencing and identification of the biosynthetic gene clusters of dynemicin has paved the way for <italic toggle="yes">in vitro</italic> studies of these biosynthetic enzymes (Gao &#x00026; Thorson, 2008<xref rid="bb13" ref-type="bibr"> &#x025b8;</xref>). The putative biosynthesis of dynemicin is correspondingly complex: the <italic toggle="yes">M.&#x000a0;chersina</italic> whole genome sequence analysis revealed 60 open reading frames (ORFs) within the biosynthetic gene cluster related to dynemicin production. Using homology to other characterized genomes, these genes have been annotated to suggest functions such as biosynthesis of the enediyne core, maturation and regulation, while there are also those with as yet unknown functions (Gao &#x00026; Thorson, 2008<xref rid="bb13" ref-type="bibr"> &#x025b8;</xref>). The gene cluster contains a common iterative type I polyketide synthase (PKSE) that is essential for the biosynthesis of a precursor polyene (heptaene) which, in the presence of other accessory enzymes, forms the ten-membered enediyne core of dynemicin (Liu <italic toggle="yes">et al.</italic>, 2003<xref rid="bb21" ref-type="bibr"> &#x025b8;</xref>). Evidence has accumulated that the PKSE product is also the precursor of the anthraquinone, and the biosynthesis of this moiety proceeds through a &#x003b4;-thiolactone iodoanthracene intermediate (Cohen &#x00026; Townsend, 2018<xref rid="bb9" ref-type="bibr"> &#x025b8;</xref>). While some insight into the conversion of the iodo&#x000ad;anthracene to the anthraquinone has recently been reported upon examination of the biosynthesis of sungeidines (Ma <italic toggle="yes">et al.</italic>, 2021<xref rid="bb22" ref-type="bibr"> &#x025b8;</xref>), which, like dynemicin, are anthraquinone-fused ten-membered enediynes, the steps leading to the iodoanthracene in addition to the enediyne core remain mostly unknown.</p><p>This study targets one of several proteins of unknown function encoded by a gene within the biosynthetic gene cluster of dynemicin, herein named DynF. The gene encoding DynF was originally annotated <italic toggle="yes">orf15</italic> (Gao &#x00026; Thorson, 2008<xref rid="bb13" ref-type="bibr"> &#x025b8;</xref>) and was deposited as ORF18 with unknown function (GenBank accession No. ACB47058.1). The DynF ortholog Sgd15 was very recently demonstrated by gene inactivation to be essential for sungeidine biosynthesis, and no intermediates, including the iodoanthracene, were detected (Ma <italic toggle="yes">et al.</italic>, 2021<xref rid="bb22" ref-type="bibr"> &#x025b8;</xref>), suggesting that DynF and Sgd15 are involved in the early steps of processing the PKSE product to either the enediyne core or iodoanthracene, or potentially both. Here, we report the structural characterization of DynF using X-ray crystallo&#x000ad;graphy as an initial step towards deciphering its role in the biosynthesis of this unique anthraquinone-fused enediyne.</p></sec><sec sec-type="materials|methods" id="sec2"><label>2.</label><title>Materials and methods</title><sec id="sec2.1"><label>2.1.</label><title>Macromolecule production</title><p>A construct for DynF from <italic toggle="yes">M. chersina</italic> ATCC53710 with a cleavable 6&#x000d7;His expression and purification tag on the N-terminus was codon-optimized for production in <italic toggle="yes">Escherichia coli</italic>. It was ordered as a synthetic gBlock from Integrated DNA Technologies (IDT, Coralville, Iowa, USA). Amplification of the gene was performed by polymerase chain reaction (PCR) using Q5 High-Fidelity 2&#x000d7; Master Mix (NEB, Westwood, Massachusetts, USA). Gibson assembly was used to clone the gene into a pNIC28-Bsa4 vector (Savitsky <italic toggle="yes">et al.</italic>, 2010<xref rid="bb29" ref-type="bibr"> &#x025b8;</xref>; Addgene, Watertown, Masachusetts, USA). It was then transformed into DH5&#x003b1; competent <italic toggle="yes">E. coli</italic> cells (Invitrogen, Carlsbad, California, USA). Sanger sequencing (Genewiz, South Plainfield, New Jersey, USA) was used to verify the sequence of the construct.</p><p>The DynF_pNIC28-Bsa4 plasmid was transformed into competent <italic toggle="yes">E. coli</italic> BL21 (DE3) expression cells (Agilent Technologies, Cedar Creek, Texas, USA). 5&#x02005;&#x000b5;l of the transformed cells were then grown overnight on Luria&#x02013;Bertani (LB) agar plates containing 50&#x02005;&#x000b5;g&#x02005;ml<sup>&#x02212;1</sup> kanamycin antibiotic. From a single colony, a seed culture of 50&#x02005;ml was grown in LB medium supplemented with 50&#x02005;&#x000b5;g&#x02005;ml<sup>&#x02212;1</sup> kanamycin to select for expression in the cells. DynF was expressed in BL21 (DE3) competent <italic toggle="yes">E. coli</italic> cells and was most soluble when induced with 0.5&#x02005;m<italic toggle="yes">M</italic> isopropyl &#x003b2;-<sc>d</sc>-1-thiogalactopyranoside (IPTG) and cultured at 291&#x02005;K after induction. To obtain suitable quantities of DynF protein for crystallization experiments, 1&#x02005;l culture was grown from a 50&#x02005;ml overnight seed culture until an OD<sub>600</sub> of &#x0223c;0.6&#x02013;0.8 was reached. The cells were then induced with 0.5&#x02005;m<italic toggle="yes">M</italic> IPTG and cultured at 291&#x02005;K for 17&#x02005;h. These cells were harvested by centrifugation at 5000&#x02005;rev&#x02005;min<sup>&#x02212;1</sup> for 40&#x02005;min.</p><p>The cell pellet was resuspended using a lysis buffer consisting of 10% glycerol, 20&#x02005;m<italic toggle="yes">M</italic> imidazole, 50&#x02005;m<italic toggle="yes">M</italic> 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) pH 8.0, 500&#x02005;m<italic toggle="yes">M</italic> NaCl, 1&#x02005;m<italic toggle="yes">M</italic> tris(2-carboxyethyl)phosphine hydrochloride (TCEP). The cells were then lysed by sonication for 4&#x02005;min 30&#x02005;s pulse on and 2&#x02005;min pulse off with 50% amplitude (Qsonica Q700 sonicator, Newton, Connecticut, USA). The lysed cells were centrifuged at 20&#x02005;000&#x02005;rev&#x02005;min<sup>&#x02212;1</sup> for 45&#x02005;min. Immobilized metal-affinity chromatography (IMAC) with Ni&#x02013;NTA resin (Qiagen, Hilden, Germany) was used to purify the protein. The protein was eluted from the nickel column using a buffer consisting of 10% glycerol, 500&#x02005;m<italic toggle="yes">M</italic> imidazole, 25&#x02005;m<italic toggle="yes">M</italic> HEPES pH 8.0, 500&#x02005;m<italic toggle="yes">M</italic> NaCl, 1&#x02005;m<italic toggle="yes">M</italic> TCEP. Sodium dodecyl sulfate&#x02013;polyacrylamide gel electrophoresis (SDS&#x02013;PAGE) was used to confirm the production of DynF protein with an expected size of 22.6&#x02005;kDa. The protein was concentrated and buffer-exchanged into Tobacco etch virus (TEV) protease buffer (25&#x02005;m<italic toggle="yes">M</italic> Tris pH 8.0, 150&#x02005;m<italic toggle="yes">M</italic> NaCl, 1&#x02005;m<italic toggle="yes">M</italic> DTT) using an Amicon ultracentrifugal filter (10&#x02005;000 molecular-weight cutoff, Merck KGaA, Darmstadt, Germany). The protein concentration was obtained using a UV&#x02013;Vis spectrophotometer with an extinction coefficient of 1.191, and was confirmed using a NanoDrop. The histidine tag at the N-terminus of the DynF protein was cleaved from the protein using His-tagged TEV protease. Subtractive nickel column purification was performed to remove the uncleaved protein and protease. DynF was run on a size-calibrated HiLoad 16/600 Superdex 200 pg (GE Healthcare, Uppsala, Sweden) size-exclusion column (SEC) to further purify it and analyze its oligomeric state (<ext-link xlink:href="#suppinfoanchor" ext-link-type="uri">Supplementary Fig. S1</ext-link>). Macromolecule-production information is summarized in Table 1<xref rid="table1" ref-type="table"> &#x025b8;</xref>.</p></sec><sec id="sec2.2"><label>2.2.</label><title>Crystallization</title><p>DynF was concentrated to 20&#x02005;mg&#x02005;ml<sup>&#x02212;1</sup> and subjected to high-throughput crystallization screening. A Mosquito LCP robot (SPT Labtech) was used with commercially available screens, including Wizard 1 and 2 and Wizard 3 and 4 (Rikagu Reagents, Bainbridge Island, Washington, USA), PEGRx and Crystal Screen HT (Hampton Research, Aliso Viejo, California, USA). Screens were set up via the sitting-drop vapor-diffusion method in MRC 2 96-well crystallization plates (Hampton Research, Aliso Viejo, California, USA) with drops consisting of 200&#x02005;nl protein solution (20&#x02005;mg&#x02005;ml<sup>&#x02212;1</sup>) mixed with 200&#x02005;nl reservoir solution. Initial crystal hits (Fig. 2<xref rid="fig2" ref-type="fig"> &#x025b8;</xref>
<italic toggle="yes">a</italic>) were observed in two wells of the Wizard 3 and 4 crystallization screen [C1, 10%(<italic toggle="yes">w</italic>/<italic toggle="yes">v</italic>) PEG 1000, 10%(<italic toggle="yes">w</italic>/<italic toggle="yes">v</italic>) PEG 8000; F10, 25%(<italic toggle="yes">w</italic>/<italic toggle="yes">v</italic>) PEG 1500, 0.1&#x02005;<italic toggle="yes">M</italic> PCB buffer pH 7.0]. Optimization for larger crystals from well F10 of the Wizard 3 and 4 crystallization screen was achieved by increasing the protein:precipitant ratio (300:200&#x02005;nl) in the initial drop (Fig. 2<xref rid="fig2" ref-type="fig"> &#x025b8;</xref>
<italic toggle="yes">b</italic>). Potassium iodide (KI) derivatives were prepared by soaking native DynF crystals for 30&#x02005;s in 0.5&#x02005;m<italic toggle="yes">M</italic> KI dissolved in the reservoir solution. Native and KI-soaked crystals were looped using Mounted CryoLoops (Hampton Research, Aliso Viejo, California, USA), cryocooled in liquid nitrogen and shipped to the Advanced Photon Source synchrotron facility at Argonne National Laboratory. Crystallization information is summarized in Table 2<xref rid="table2" ref-type="table"> &#x025b8;</xref>.</p></sec><sec id="sec2.3"><label>2.3.</label><title>Data collection and processing</title><p>X-ray diffraction data were collected remotely at wavelengths of 1.0332 and 1.823&#x02005;&#x000c5; for the native crystals and the heavy-atom derivative crystals, respectively. The native and iodide-soaked crystals diffracted to resolutions of 1.55 and 2.38&#x02005;&#x000c5;, respectively. The DynF diffraction data were indexed in the orthorhombic space group <italic toggle="yes">C</italic>222<sub>1</sub>, with unit-cell parameters <italic toggle="yes">a</italic>&#x000a0;=&#x000a0;60, <italic toggle="yes">b</italic> = 65, <italic toggle="yes">c</italic> = 131&#x02005;&#x000c5;. The diffraction data were integrated and scaled using <italic toggle="yes">XDS</italic> (Kabsch, 2010<italic toggle="yes">a</italic>
<xref rid="bb16" ref-type="bibr"> &#x025b8;</xref>,<italic toggle="yes">b</italic>
<xref rid="bb17" ref-type="bibr"> &#x025b8;</xref>). Data-collection and processing statistics are summarized in Table 3<xref rid="table3" ref-type="table"> &#x025b8;</xref>.</p></sec><sec id="sec2.4"><label>2.4.</label><title>Structure solution and refinement</title><p>The SAD (single-wavelength anomalous diffraction) and SIRAS (single isomorphous replacement with anomalous scattering) methods were used to phase the structure of DynF. Scaling, substructure solution and phasing were accomplished with <italic toggle="yes">SHELXC</italic>/<italic toggle="yes">D</italic>/<italic toggle="yes">E</italic> (Sheldrick, 2010<xref rid="bb32" ref-type="bibr"> &#x025b8;</xref>) using the <italic toggle="yes">HKL</italic>2<italic toggle="yes">MAP</italic> graphical interface (Pape &#x00026; Schneider, 2004<xref rid="bb28" ref-type="bibr"> &#x025b8;</xref>). Automated protein tracing with <italic toggle="yes">ARP</italic>/<italic toggle="yes">wARP</italic> (Langer <italic toggle="yes">et al.</italic>, 2008<xref rid="bb20" ref-type="bibr"> &#x025b8;</xref>) was used on both the SAD and the SIRAS maps to build 418 of 422 residues.</p><p>Refinement and model building were performed using <italic toggle="yes">phenix.refine</italic> (Afonine <italic toggle="yes">et al.</italic>, 2012<xref rid="bb2" ref-type="bibr"> &#x025b8;</xref>) and <italic toggle="yes">Coot</italic> (Emsley <italic toggle="yes">et al.</italic>, 2010<xref rid="bb12" ref-type="bibr"> &#x025b8;</xref>). The structure was visualized using a collaborative 3D graphics system (Yennamalli <italic toggle="yes">et al.</italic>, 2014<xref rid="bb37" ref-type="bibr"> &#x025b8;</xref>). The software applications used in this project were compiled and configured by SBGrid (Morin <italic toggle="yes">et al.</italic>, 2013<xref rid="bb23" ref-type="bibr"> &#x025b8;</xref>). The structure of DynF and its corresponding diffraction data have been deposited in the worldwide Protein Data Bank (wwPDB; Berman <italic toggle="yes">et al.</italic>, 2003<xref rid="bb6" ref-type="bibr"> &#x025b8;</xref>) as entry <ext-link xlink:href="https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&#x00026;pdbId=6ubl" ext-link-type="uri">6ubl</ext-link>. Refinement statistics are summarized in Table 4<xref rid="table4" ref-type="table"> &#x025b8;</xref>.</p></sec><sec id="sec2.5"><label>2.5.</label><title>Ligand determination using gas chromatography&#x02013;mass spectrometry (GC-MS)</title><p>Acetonitrile (0.5&#x02005;ml) was added to 0.5&#x02005;ml purified DynF protein (40&#x02005;mg&#x02005;ml<sup>&#x02212;1</sup>) and rotated at room temperature for 2&#x02005;h. The mixture was centrifuged using a protein concentrator (3000 molecular-weight cutoff; Millipore, Cork, Ireland) at 4000&#x02005;rev&#x02005;min<sup>&#x02212;1</sup> for 20&#x02005;min, and the acetonitrile extract (100&#x02005;&#x000b5;l) was filtered to remove any remaining insoluble debris. Gas chromatography&#x02013;mass spectrometry (GC-MS) analysis was performed using an Agilent 7890 GC with a 30&#x02005;m &#x000d7; 250&#x02005;&#x000b5;m &#x000d7; 0.25&#x02005;mm HP-5ms UI capillary column and an Agilent G7081B MSD. Helium was the carrier gas at a flow rate of 1&#x02005;ml&#x02005;min<sup>&#x02212;1</sup>. The temperatures of the injector, the interface and the liner were 523&#x02005;K. Injections of 5&#x02005;&#x000b5;l were performed in splitless mode. The column temperature was initially 343&#x02005;K and was held for 2&#x02005;min, increased to 513&#x02005;K at 277&#x02005;K&#x02005;min<sup>&#x02212;1</sup> and run for a total run time of 59.5&#x02005;min. For GC&#x02013;MS detection, an electron-impact ionization system was used. The mass range was set to 50&#x02013;500&#x02005;<italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> with a filament delay of 4&#x02005;min. The sample-injection volume was 1&#x02005;&#x000b5;l.</p></sec><sec id="sec2.6"><label>2.6.</label><title>Co-expression of DynF with SgcE and DynE7</title><p>The genes encoding the C-1027 polyketide synthase SgcE and dynemicin thioesterase DynE7 were cloned into pETDuet using standard procedures. The gene encoding DynF was cloned into pDB.His.MBP. All genes were sequenced to confirm their identity. Both pETDuet and pDB.His.MBP plasmids with the respective genes were co-transformed into <italic toggle="yes">E. coli</italic> BL21 (DE3) cells. The transformed cells were plated on LB agar supplemented with 50&#x02005;&#x000b5;g&#x02005;ml<sup>&#x02212;1</sup> kanamycin and 50&#x02005;&#x000b5;g&#x02005;ml<sup>&#x02212;1</sup> carbenicillin. After overnight incubation at 310&#x02005;K, a single colony was used to inoculate 5&#x02005;ml LB medium supplemented with 50&#x02005;&#x000b5;g&#x02005;ml<sup>&#x02212;1</sup> kanamycin and 50&#x02005;&#x000b5;g&#x02005;ml<sup>&#x02212;1</sup> carbenicillin. Incubation was performed overnight at 310&#x02005;K with shaking at 250&#x02005;rev&#x02005;min<sup>&#x02212;1</sup>. The culture (0.5&#x02005;ml) was transferred into 50&#x02005;ml fresh LB supplemented with 50&#x02005;&#x000b5;g&#x02005;ml<sup>&#x02212;1</sup> kanamycin and 50&#x02005;&#x000b5;g&#x02005;ml<sup>&#x02212;1</sup> carbenicillin and incubated at 291&#x02005;K and 250&#x02005;rev&#x02005;min<sup>&#x02212;1</sup>. When the optical density at 600&#x02005;nm reached 0.5&#x02013;0.6, expression was induced with sterile IPTG solution (final concentration 0.1&#x02005;m<italic toggle="yes">M</italic>) and incubated at 291&#x02005;K and 250&#x02005;rev&#x02005;min<sup>&#x02212;1</sup> for an additional 36&#x02005;h. The cells were centrifuged at 4000&#x02005;rev&#x02005;min<sup>&#x02212;1</sup> at 277&#x02005;K for 30&#x02005;min, and the wet pellet was washed once with 30&#x02005;ml phosphate buffer pH 7.2. The pellet was resuspended in 30&#x02005;ml phosphate buffer pH 7.2 and sonicated for 2&#x02005;min with 10&#x02005;s pulse on and 50&#x02005;s pulse off (with 40% amplitude) on ice. The lysate was purified using nickel resin and then with amylose resin to purify the MBP-tagged DynF. The sample was extracted with acetonitrile and analyzed by GC-MS as described above.</p></sec></sec><sec sec-type="discussion|interpretation" id="sec3"><label>3.</label><title>Results and discussion</title><p>The structure of DynF was determined to a resolution of 1.50&#x02005;&#x000c5; with a final <italic toggle="yes">R</italic>
<sub>work</sub> and <italic toggle="yes">R</italic>
<sub>free</sub> of 0.16 and 0.19, respectively. The DynF crystal has two molecules in its asymmetric unit (Fig. 3<xref rid="fig3" ref-type="fig"> &#x025b8;</xref>
<italic toggle="yes">a</italic>). An analysis of the crystal contacts with <italic toggle="yes">PISA</italic> (Krissinel &#x00026; Henrick, 2007<xref rid="bb18" ref-type="bibr"> &#x025b8;</xref>) predicts that DynF forms a stable dimer. Size-exclusion chromatography (SEC) showed that DynF could exist in a higher oligomeric state in solution (<ext-link xlink:href="#suppinfoanchor" ext-link-type="uri">Supplementary Fig. S1</ext-link>).</p><p>DynF is comprised of antiparallel &#x003b2;-sheets that are connected by short loops and helical segments to form eight-stranded antiparallel &#x003b2;-barrels (<ext-link xlink:href="#suppinfoanchor" ext-link-type="uri">Supplementary Fig. S2</ext-link>). The &#x003b2;-strands of the DynF structure are labeled 1, 2, 3, 4a/4b, 5a/5b, 6a/6b, 7a/7b and 8. Two short helical segments connect &#x003b2;-strands 2/3 and 5b/6a. The topology of DynF shows that each strand is directly linked to its neighbor, which is typical of most topologies of eight-stranded antiparallel &#x003b2;-barrels (Fig.&#x000a0;3<xref rid="fig3" ref-type="fig"> &#x025b8;</xref>
<italic toggle="yes">b</italic>) such as outer membrane proteins, avidins, fatty-acid binding proteins and lysozyme inhibitors (Geerds <italic toggle="yes">et al.</italic>, 2014<xref rid="bb14" ref-type="bibr"> &#x025b8;</xref>). Deviating from a canonical eight-stranded, up&#x02013;down &#x003b2;-barrel (Lalonde <italic toggle="yes">et al.</italic>, 1994<xref rid="bb19" ref-type="bibr"> &#x025b8;</xref>), we observed short loops inserted within strands 4, 5, 6 and 7 (Figs. 3<xref rid="fig3" ref-type="fig"> &#x025b8;</xref>
<italic toggle="yes">a</italic> and 3<xref rid="fig3" ref-type="fig"> &#x025b8;</xref>
<italic toggle="yes">b</italic>). Some of the loop residues within strands 6 and 7 are located at the dimer interface and thus may be involved in stabilization of the dimer (<ext-link xlink:href="#suppinfoanchor" ext-link-type="uri">Supplementary Fig. S3</ext-link>, <ext-link xlink:href="#suppinfoanchor" ext-link-type="uri">Supplementary Tables S1 and S2</ext-link>).</p><p>Comparative analysis of protein structures can help to decipher their functions. The DynF structure was compared with other structures in the Protein Data Bank (PDB) using the <italic toggle="yes">DALI</italic> server (Holm, 2020<xref rid="bb15" ref-type="bibr"> &#x025b8;</xref>). DynF did not have significant structural similarities to previous structures (<italic toggle="yes">Z</italic>-score of &#x0003c;10; structural identity of &#x0003c;15%; <ext-link xlink:href="#suppinfoanchor" ext-link-type="uri">Supplementary Table S3</ext-link>, <ext-link xlink:href="#suppinfoanchor" ext-link-type="uri">Supplementary Fig. S4</ext-link>), suggesting that DynF represents a novel fold, thus lacking precedents for providing a known mechanism.</p><p>The electron-density map of DynF revealed an elongated ligand embedded within the &#x003b2;-barrel (Fig. 3<xref rid="fig3" ref-type="fig"> &#x025b8;</xref>
<italic toggle="yes">c</italic>). The size and shape of the ligand, as well as its binding environment, are suggestive of a 16-carbon fatty acid, which was confirmed by gas chromatography&#x02013;mass spectrometry (GC-MS) as palmitic acid (<ext-link xlink:href="#suppinfoanchor" ext-link-type="uri">Supplementary Fig. S5</ext-link>). Palmitic acid is the most abundant fatty acid expressed in <italic toggle="yes">E. coli</italic> cells (Cronan &#x00026; Thomas, 2009<xref rid="bb10" ref-type="bibr"> &#x025b8;</xref>). We hypothesize that the ligand co-purified with the protein. The surface representation of DynF in <italic toggle="yes">PyMOL</italic> reveals that the binding cavity of the ligand is closed and may thus require the channel within the ligand-binding site to open and close in order to allow the ligand to enter and exit.</p><p>The hydrophobicity of the side chains of the residues in the ligand-binding cavity (Fig. 3<xref rid="fig3" ref-type="fig"> &#x025b8;</xref>
<italic toggle="yes">d</italic>) and the presence of palmitic acid suggest that DynF may be involved in the binding or processing of the PKSE product or an early biosynthetic intermediate, which is consistent with the results from the inactivation of <italic toggle="yes">sgd15</italic> (Ma <italic toggle="yes">et al.</italic>, 2021<xref rid="bb22" ref-type="bibr"> &#x025b8;</xref>). A linear conjugated heptaene has previously been observed upon heterologous co-expression of the genes encoding PKSE and a type II thioesterase in <italic toggle="yes">E. coli</italic> (Annaval <italic toggle="yes">et al.</italic>, 2017<xref rid="bb3" ref-type="bibr"> &#x025b8;</xref>; Smanski <italic toggle="yes">et al.</italic>, 2011<xref rid="bb33" ref-type="bibr"> &#x025b8;</xref>), and was hypothesized to potentially serve as the DynF ligand or substrate. To test this, DynF was co-expressed with a C-1027 polyketide synthase, SgcE, and a dynemicin thio&#x000ad;estarase, DynE7. However, GC-MS analysis of the ligand following purification of DynF after co-expression of the three genes gave an identical profile predominantly containing palmitic acid. Thus, the role of DynF has not directly been confirmed. Nonetheless, the structural data now provide insight into its potential role in binding the precursor polyene and provide an opportunity to further explore this role via <italic toggle="yes">in vitro</italic> assays.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material position="float" content-type="local-data"><p>PDB reference: <ext-link xlink:href="6ubl" ext-link-type="pdb">DynF from <italic toggle="yes">Micromonospora chersina</italic>, 6ubl</ext-link>
</p></supplementary-material><supplementary-material position="float" content-type="local-data"><p>Supplementary Figures and Tables. DOI: <ext-link xlink:href="https://doi.org/10.1107/S2053230X21012322/ft5115sup1.pdf" ext-link-type="uri">10.1107/S2053230X21012322/ft5115sup1.pdf</ext-link>
</p><media xlink:href="f-78-00001-sup1.pdf" id="d64e159" position="anchor"/></supplementary-material></sec></body><back><ack><p>This work used research resources provided by the Center of Biomedical Research Excellence (COBRE) in Pharmaceutical Research and Innovation (CPRI; NIH P20 GM130456), the University of Kentucky College of Pharmacy and the National Center for Advancing Translational Sciences (UL1TR000117 and UL1TR001998). This research used resources of the Advanced Photon Source, a US Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. GM/CA@APS has been funded by the National Cancer Institute (ACB-12002) and the National Institute of General Medical Sciences (AGM-12006, P30GM138396). This content is solely the responsibility of the authors and does not necessarily represent the official views of the National institutes of Health or the National Science Foundation.</p></ack><ref-list><title>References</title><ref id="bb1"><mixed-citation publication-type="other">Abe, S. &#x00026; Otsuki, M. (2002). <italic toggle="yes">Curr. Med. Chem. Anticancer Agents</italic>, <bold>2</bold>, 715&#x02013;726.</mixed-citation></ref><ref id="bb2"><mixed-citation publication-type="other">Afonine, P. V., Grosse-Kunstleve, R. W., Echols, N., Headd, J. J., Moriarty, N. W., Mustyakimov, M., Terwilliger, T. C., Urzhumtsev, A., Zwart, P. H. &#x00026; Adams, P. D. (2012). <italic toggle="yes">Acta Cryst.</italic> D<bold>68</bold>, 352&#x02013;367.</mixed-citation></ref><ref id="bb3"><mixed-citation publication-type="other">Annaval, T., Rudolf, J., Chang, C., Lohman, J., Kim, Y., Bigelow, L., Jedrzejczak, R., Babnigg, G., Joachimiak, A., Phillips, G. &#x00026; Shen, B. (2017). <italic toggle="yes">ACS Omega</italic>, <bold>2</bold>, 5159&#x02013;5169.</mixed-citation></ref><ref id="bb4"><mixed-citation publication-type="other">Avenda&#x000f1;o, C. &#x00026; Men&#x000e9;ndez, J. C. (2015). <italic toggle="yes">Medicinal Chemistry of Anticancer Drugs</italic>, 2nd ed, pp. 133&#x02013;195. Amsterdam: Elsevier.</mixed-citation></ref><ref id="bb5"><mixed-citation publication-type="other">Beis, K. &#x00026; Rebuffat, S. (2019). <italic toggle="yes">Res. Microbiol.</italic>
<bold>170</bold>, 399&#x02013;406.</mixed-citation></ref><ref id="bb6"><mixed-citation publication-type="other">Berman, H. M., Henrick, K. &#x00026; Nakamura, H. (2003). <italic toggle="yes">Nat. Struct. Mol. Biol.</italic>
<bold>10</bold>, 980.</mixed-citation></ref><ref id="bb7"><mixed-citation publication-type="other">Biggins, J., Onwueme, K. C. &#x00026; Thorson, J. S. (2003). <italic toggle="yes">Science</italic>, <bold>301</bold>, 1537&#x02013;1541.</mixed-citation></ref><ref id="bb8"><mixed-citation publication-type="other">Bond, C. S. (2003). <italic toggle="yes">Bioinformatics</italic>, <bold>19</bold>, 311&#x02013;312.</mixed-citation></ref><ref id="bb9"><mixed-citation publication-type="other">Cohen, D. &#x00026; Townsend, C. (2018). <italic toggle="yes">Angew. Chem.</italic>
<bold>130</bold>, 5752&#x02013;5756.</mixed-citation></ref><ref id="bb10"><mixed-citation publication-type="other">Cronan, J. &#x00026; Thomas, J. (2009). <italic toggle="yes">Methods Enzymol.</italic>
<bold>459</bold>, 395&#x02013;433.</mixed-citation></ref><ref id="bb11"><mixed-citation publication-type="other">Elshahawi, S. I., Ramelot, T. A., Seetharaman, J., Chen, J., Singh, S., Yang, Y., Pederson, K., Kharel, M. K., Xiao, R., Lew, S., Yennamalli, R. M., Miller, M. D., Wang, F., Tong, L., Montelione, G. T., Kennedy, M. A., Bingman, C. A., Zhu, H., Phillips, G. N. Jr &#x00026; Thorson, J. S. (2014). <italic toggle="yes">ACS Chem. Biol.</italic>
<bold>9</bold>, 2347&#x02013;2358.</mixed-citation></ref><ref id="bb12"><mixed-citation publication-type="other">Emsley, P., Lohkamp, B., Scott, W. G. &#x00026; Cowtan, K. (2010). <italic toggle="yes">Acta Cryst.</italic> D<bold>66</bold>, 486&#x02013;501.</mixed-citation></ref><ref id="bb13"><mixed-citation publication-type="other">Gao, Q. &#x00026; Thorson, J. (2008). <italic toggle="yes">FEMS Microb. Lett.</italic>
<bold>282</bold>, 105&#x02013;114.</mixed-citation></ref><ref id="bb14"><mixed-citation publication-type="other">Geerds, C., Wohlmann, J., Haas, A. &#x00026; Niemann, H. H. (2014). <italic toggle="yes">Acta Cryst.</italic> F<bold>70</bold>, 866&#x02013;871.</mixed-citation></ref><ref id="bb15"><mixed-citation publication-type="other">Holm, L. (2020). <italic toggle="yes">Methods Mol. Biol.</italic>
<bold>2112</bold>, 29&#x02013;42.</mixed-citation></ref><ref id="bb16"><mixed-citation publication-type="other">Kabsch, W. (2010<italic toggle="yes">a</italic>). <italic toggle="yes">Acta Cryst.</italic> D<bold>66</bold>, 125&#x02013;132.</mixed-citation></ref><ref id="bb17"><mixed-citation publication-type="other">Kabsch, W. (2010<italic toggle="yes">b</italic>). <italic toggle="yes">Acta Cryst.</italic> D<bold>66</bold>, 133&#x02013;144.</mixed-citation></ref><ref id="bb18"><mixed-citation publication-type="other">Krissinel, E. &#x00026; Henrick, K. (2007). <italic toggle="yes">J. Mol. Biol.</italic>
<bold>372</bold>, 774&#x02013;797.</mixed-citation></ref><ref id="bb19"><mixed-citation publication-type="other">Lalonde, J., Bernlohr, D. &#x00026; Banaszak, L. (1994). <italic toggle="yes">FASEB J.</italic>
<bold>8</bold>, 1240&#x02013;1247.</mixed-citation></ref><ref id="bb20"><mixed-citation publication-type="other">Langer, G., Cohen, S., Lamzin, V. &#x00026; Perrakis, A. (2008). <italic toggle="yes">Nat. Protoc.</italic>
<bold>3</bold>, 1171&#x02013;1179.</mixed-citation></ref><ref id="bb21"><mixed-citation publication-type="other">Liu, W., Ahlert, J., Gao, Q., Wendt-Pienkowski, E., Shen, B. &#x00026; Thorson, J. S. (2003). <italic toggle="yes">Proc. Natl Acad. Sci. USA</italic>, <bold>100</bold>, 11959&#x02013;11963.</mixed-citation></ref><ref id="bb22"><mixed-citation publication-type="other">Ma, G., Tran, H., Low, Z., Candra, H., Pang, L., Cheang, Q., Fang, M. &#x00026; Liang, Z. (2021). <italic toggle="yes">J. Am. Chem. Soc.</italic>
<bold>143</bold>, 11500&#x02013;11509.</mixed-citation></ref><ref id="bb23"><mixed-citation publication-type="other">Morin, A., Eisenbraun, B., Key, J., Sanschagrin, P., Timony, M., Ottaviano, M. &#x00026; Sliz, P. (2013). <italic toggle="yes">eLife</italic>, <bold>2</bold>, e01456.</mixed-citation></ref><ref id="bb24"><mixed-citation publication-type="other">Myers, A., Fraley, M., Tom, N., Cohen, S. &#x00026; Madar, D. (1995). <italic toggle="yes">Chem. Biol.</italic>
<bold>2</bold>, 33&#x02013;43.</mixed-citation></ref><ref id="bb25"><mixed-citation publication-type="other">Nicolaou, K., Hummel, C., Nakada, M., Shibayama, K., Pitsinos, E., Saimoto, H., Mizuno, Y., Baldenius, K. &#x00026; Smith, A. (1993). <italic toggle="yes">J. Am. Chem. Soc.</italic>
<bold>115</bold>, 7625&#x02013;7635.</mixed-citation></ref><ref id="bb26"><mixed-citation publication-type="other">Nicolaou, K., Smith, A., Wendeborn, S. &#x00026; Hwang, C. (1991). <italic toggle="yes">J. Am. Chem. Soc.</italic>
<bold>113</bold>, 3106&#x02013;3114.</mixed-citation></ref><ref id="bb28"><mixed-citation publication-type="other">Pape, T. &#x00026; Schneider, T. R. (2004). <italic toggle="yes">J. Appl. Cryst.</italic>
<bold>37</bold>, 843&#x02013;844.</mixed-citation></ref><ref id="bb29"><mixed-citation publication-type="other">Savitsky, P., Bray, J., Cooper, C. D. O., Marsden, B. D., Mahajan, P., Burgess-Brown, N. A. &#x00026; Gileadi, O. (2010). <italic toggle="yes">J. Struct. Biol.</italic>
<bold>172</bold>, 3&#x02013;13.</mixed-citation></ref><ref id="bb30"><mixed-citation publication-type="other">Shah, N. (2017). <italic toggle="yes">Curr. Drug Targets</italic>, <bold>18</bold>, 257&#x02013;270.</mixed-citation></ref><ref id="bb31"><mixed-citation publication-type="other">Shair, M., Yoon, T., Mosny, K., Chou, T. &#x00026; Danishefsky, S. (1996). <italic toggle="yes">J. Am. Chem. Soc.</italic>
<bold>118</bold>, 9509&#x02013;9525.</mixed-citation></ref><ref id="bb32"><mixed-citation publication-type="other">Sheldrick, G. M. (2010). <italic toggle="yes">Acta Cryst.</italic> D<bold>66</bold>, 479&#x02013;485.</mixed-citation></ref><ref id="bb33"><mixed-citation publication-type="other">Smanski, M., Yu, Z., Casper, J., Lin, S., Peterson, R., Chen, Y., Wendt-Pienkowski, E., Rajski, S. &#x00026; Shen, B. (2011). <italic toggle="yes">Proc. Natl Acad. Sci. USA</italic>, <bold>108</bold>, 13498&#x02013;13503.</mixed-citation></ref><ref id="bb34"><mixed-citation publication-type="other">Sugiura, Y., Shiraki, T., Konishi, M. &#x00026; Oki, T. (1990). <italic toggle="yes">Proc. Natl Acad. Sci. USA</italic>, <bold>87</bold>, 3831&#x02013;3835.</mixed-citation></ref><ref id="bb35"><mixed-citation publication-type="other">Thorson, J., Sievers, E., Ahlert, J., Shepard, E., Whitwam, R., Onwueme, K. &#x00026; Ruppen, M. (2000). <italic toggle="yes">Curr. Pharm. Des.</italic>
<bold>6</bold>, 1841&#x02013;1879.</mixed-citation></ref><ref id="bb36"><mixed-citation publication-type="other">Van Lanen, S. &#x00026; Shen, B. (2008). <italic toggle="yes">Curr. Top. Med. Chem.</italic>
<bold>8</bold>, 448&#x02013;459.</mixed-citation></ref><ref id="bb37"><mixed-citation publication-type="other">Yennamalli, R., Arangarasan, R., Bryden, A., Gleicher, M. &#x00026; Phillips, G. N. Jr (2014). <italic toggle="yes">J. Appl. Cryst.</italic>
<bold>47</bold>, 1153&#x02013;1157.</mixed-citation></ref></ref-list></back><floats-group><fig position="float" id="fig1"><label>Figure 1</label><caption><p>Dynemicin A has a unique molecular architecture comprising an enediyne core (red) and peripheral moieties (black). The enediyne core is the key to the cytotoxicity of dynemicin.</p></caption><graphic xlink:href="f-78-00001-fig1" position="float"/></fig><fig position="float" id="fig2"><label>Figure 2</label><caption><p>DynF crystals as viewed under an Olympus BHTP polarizing microscope equipped with an Olympus OM-D E-M5 digital camera. (<italic toggle="yes">a</italic>) Initial crystal hits observed at a 1:1 ratio of protein to precipitant. (<italic toggle="yes">b</italic>) Larger crystals were obtained by increasing the amount of protein in the crystallization wells.</p></caption><graphic xlink:href="f-78-00001-fig2" position="float"/></fig><fig position="float" id="fig3"><label>Figure 3</label><caption><p>Structure of DynF. (<italic toggle="yes">a</italic>) A ribbon diagram of the crystal structure of DynF (PDB entry <ext-link xlink:href="https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&#x00026;pdbId=6ubl" ext-link-type="uri">6ubl</ext-link>) viewed down its noncrystallogaphic twofold axis. The ligand is represented as spheres embedded in the DynF &#x003b2;-barrels. Each protomer of DynF comprises an eight-stranded antiparallel &#x003b2;-barrel connected by loops and two helical segments. Strands 4, 5, 6 and 7 are interrupted by dimerization interactions. This figure was generated in <italic toggle="yes">PyMOL</italic> (version 2.4.1; Schr&#x000f6;dinger). (<italic toggle="yes">b</italic>) A topology diagram of DynF generated using <italic toggle="yes">TopDraw</italic> (Bond, 2003<xref rid="bb8" ref-type="bibr"> &#x025b8;</xref>) shows that each strand is connected to its next neighbor, as is typical of most eight-stranded antiparallel &#x003b2;-barrel structures. (<italic toggle="yes">c</italic>) The final 2<italic toggle="yes">mF</italic>
<sub>o</sub> &#x02212; <italic toggle="yes">mF</italic>
<sub>c</sub> map (contoured at 1 r.m.s.d) in blue with &#x000b1;3 r.m.s.d. contours of the polder omit map in green/red represented in <italic toggle="yes">Coot</italic>. The green positive difference density clearly shows the location of the bound ligand (palmitic acid) that was omitted from the model phases for the polder map calculation. (<italic toggle="yes">d</italic>) The ligand in the DynF structure is surrounded by hydrophobic amino-acid groups, except for residues that interact with the carboxylic group at one end of the palmitic acid. This figure was generated with the <italic toggle="yes">FLEV</italic> (<italic toggle="yes">Flatland Ligand Environment View</italic>) tool in <italic toggle="yes">Coot</italic>.</p></caption><graphic xlink:href="f-78-00001-fig3" position="float"/></fig><table-wrap position="float" id="table1"><label>Table 1</label><caption><title>Macromolecule-production information</title></caption><table frame="hsides" rules="groups"><tbody valign="top"><tr><td rowspan="1" colspan="1" align="left" valign="top">Source organism</td><td rowspan="1" colspan="1" align="left" valign="top">
<italic toggle="yes">Micromonospora chersina</italic>
</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">DNA source</td><td rowspan="1" colspan="1" align="left" valign="top">
<italic toggle="yes">E. coli</italic> codon-optimized synthesis (gBlock) from Genewiz</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Insert forward primer<xref rid="tfn1" ref-type="table-fn">&#x02020;</xref>
</td><td rowspan="1" colspan="1" align="left" valign="top">5&#x02032;-agaacctgtacttccaatccATGTCGACTAAATCTGTATT-3&#x02032;</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Insert reverse primer</td><td rowspan="1" colspan="1" align="left" valign="top">5&#x02032;-ACCAGACCAGATGTGAacggtctccagtaaaggtgg-3&#x02032;</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Vector forward primer</td><td rowspan="1" colspan="1" align="left" valign="top">5&#x02032;-TTAAACCAGACCAGATGTGAacggtctccagtaaaggtg-3&#x02032;</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Vector reverse primer</td><td rowspan="1" colspan="1" align="left" valign="top">5&#x02032;-agaacctgtacttccaatccATGTCGACTAAATCTGTATT-3&#x02032;</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Expression vector<xref rid="tfn2" ref-type="table-fn">&#x02021;</xref>
</td><td rowspan="1" colspan="1" align="left" valign="top">pNIC28-Bsa4</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Expression host</td><td rowspan="1" colspan="1" align="left" valign="top">
<italic toggle="yes">Escherichia coli</italic> BL21 (DE3)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Complete amino-acid sequence of the construct produced<xref rid="tfn3" ref-type="table-fn">&#x000a7;</xref>
</td><td rowspan="1" colspan="1" align="left" valign="top">mgsshhhhhh<underline>enlyfq/s</underline>MSTKSVLFGRPVQTEGVPNVYAGAPVVPWTPPEPGIDNLGINSIDTFAVPGVGEYTVAFDGWVRVVRSPSTSGEWADAEVYTNLIEMKMVGECEELGKITVTLNPDCLSAGQIRTPFDPYAGEGPSAKACRMAVGAIFDMPKLGLKLMNREPIILTIDDVRSIPPAGAPGKGQIYRMMPLLDVNDPDGQPVAYLTSLRFNMGGYLKPDQM</td></tr></tbody></table><table-wrap-foot><fn id="tfn1"><label>&#x02020;</label><p>The primers contained overhangs for cloning, which are represented as lower case letters.</p></fn><fn id="tfn2"><label>&#x02021;</label><p>Plasmid pNIC28-Bsa4 was a gift from Opher Gileadi (Addgene plasmid #26103).</p></fn><fn id="tfn3"><label>&#x000a7;</label><p>The expression and purification tag is shown in lower case with the TEV recognition site underlined and the cut site indicated with a slash.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="table2"><label>Table 2</label><caption><title>Crystallization</title></caption><table frame="hsides" rules="groups"><tbody valign="top"><tr><td rowspan="1" colspan="1" align="left" valign="top">Method</td><td rowspan="1" colspan="1" align="left" valign="top">Vapor diffusion, sitting drop</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Plate type</td><td rowspan="1" colspan="1" align="left" valign="top">MRC 2 (96-well crystallization plate)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Temperature (K)</td><td rowspan="1" colspan="1" align="left" valign="top">293</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Protein concentration (mg&#x02005;ml<sup>&#x02212;1</sup>)</td><td rowspan="1" colspan="1" align="left" valign="top">20</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Buffer composition of protein solution (crystallization buffer)</td><td rowspan="1" colspan="1" align="left" valign="top">0.025&#x02005;<italic toggle="yes">M</italic> Tris pH 8.0, 0.15&#x02005;<italic toggle="yes">M</italic> NaCl, 1&#x02005;m<italic toggle="yes">M</italic> DTT</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Composition of reservoir solution</td><td rowspan="1" colspan="1" align="left" valign="top">25%(<italic toggle="yes">w</italic>/<italic toggle="yes">v</italic>) PEG 1500, 0.1&#x02005;<italic toggle="yes">M</italic> PCB buffer pH 7.0</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Volume and ratio of drop<xref rid="tfn4" ref-type="table-fn">&#x02020;</xref>
</td><td rowspan="1" colspan="1" align="left" valign="top">300&#x02005;nl (1.5:1)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Volume of reservoir (&#x000b5;l)</td><td rowspan="1" colspan="1" align="left" valign="top">50&#x02005;</td></tr></tbody></table><table-wrap-foot><fn id="tfn4"><label>&#x02020;</label><p>The initial screening for crystals was performed using a 1:1 ratio of protein to reservoir solution.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="table3"><label>Table 3</label><caption><title>Data collection and processing</title><p>Values in parentheses are for the outer shell.</p></caption><table frame="hsides" rules="groups"><thead valign="top"><tr><th style="border-bottom:1px solid black;" rowspan="1" colspan="1" align="left" valign="top">&#x000a0;</th><th style="border-bottom:1px solid black;" rowspan="1" colspan="1" align="left" valign="top">Native</th><th style="border-bottom:1px solid black;" rowspan="1" colspan="1" align="left" valign="top">KI soaked</th></tr></thead><tbody valign="top"><tr><td rowspan="1" colspan="1" align="left" valign="top">Diffraction source</td><td rowspan="1" colspan="1" align="left" valign="top">Beamline 23-ID-B, APS</td><td rowspan="1" colspan="1" align="left" valign="top">Beamline 23-ID-B, APS</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Wavelength (&#x000c5;)</td><td rowspan="1" colspan="1" align="left" valign="top">1.0332</td><td rowspan="1" colspan="1" align="left" valign="top">1.8233</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Temperature (K)</td><td rowspan="1" colspan="1" align="left" valign="top">100</td><td rowspan="1" colspan="1" align="left" valign="top">100</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Detector</td><td rowspan="1" colspan="1" align="left" valign="top">Dectris EIGER X 16M</td><td rowspan="1" colspan="1" align="left" valign="top">Dectris EIGER X 16M</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Crystal-to-detector distance (mm)</td><td rowspan="1" colspan="1" align="left" valign="top">219.1</td><td rowspan="1" colspan="1" align="left" valign="top">199.4</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Rotation range per image (&#x000b0;)</td><td rowspan="1" colspan="1" align="left" valign="top">0.2</td><td rowspan="1" colspan="1" align="left" valign="top">0.2</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Total rotation range (&#x000b0;)</td><td rowspan="1" colspan="1" align="left" valign="top">180</td><td rowspan="1" colspan="1" align="left" valign="top">360</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Exposure time per image (s)</td><td rowspan="1" colspan="1" align="left" valign="top">0.2</td><td rowspan="1" colspan="1" align="left" valign="top">0.2</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Space group</td><td rowspan="1" colspan="1" align="left" valign="top">
<italic toggle="yes">C</italic>222<sub>1</sub>
</td><td rowspan="1" colspan="1" align="left" valign="top">
<italic toggle="yes">C</italic>222<sub>1</sub>
</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">
<italic toggle="yes">a</italic>, <italic toggle="yes">b</italic>, <italic toggle="yes">c</italic> (&#x000c5;)</td><td rowspan="1" colspan="1" align="left" valign="top">59.83, 116.13, 129.88</td><td rowspan="1" colspan="1" align="left" valign="top">59.93, 116.08, 131.03</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Mosaicity (&#x000b0;)</td><td rowspan="1" colspan="1" align="left" valign="top">0.14</td><td rowspan="1" colspan="1" align="left" valign="top">0.15</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Resolution range (&#x000c5;)</td><td rowspan="1" colspan="1" align="left" valign="top">34.7&#x02013;1.50 (1.59&#x02013;1.50)</td><td rowspan="1" colspan="1" align="left" valign="top">49.3&#x02013;2.38 (2.53&#x02013;2.40)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Total No. of reflections</td><td rowspan="1" colspan="1" align="left" valign="top">440004 (21559)</td><td rowspan="1" colspan="1" align="left" valign="top">198086 (8709)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">No. of unique reflections</td><td rowspan="1" colspan="1" align="left" valign="top">70922 (5926)</td><td rowspan="1" colspan="1" align="left" valign="top">17513 (1990)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Completeness (%)</td><td rowspan="1" colspan="1" align="left" valign="top">97.6 (87.1)</td><td rowspan="1" colspan="1" align="left" valign="top">93.7 (66.8)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Multiplicity</td><td rowspan="1" colspan="1" align="left" valign="top">6.2 (3.9)</td><td rowspan="1" colspan="1" align="left" valign="top">11.3 (4.4)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02329;<italic toggle="yes">I</italic>/&#x003c3;(<italic toggle="yes">I</italic>)&#x0232a;</td><td rowspan="1" colspan="1" align="left" valign="top">14.1 (0.63)<xref rid="tfn5" ref-type="table-fn">&#x02020;</xref>
</td><td rowspan="1" colspan="1" align="left" valign="top">14.1 (1.8)<xref rid="tfn6" ref-type="table-fn">&#x02021;</xref>
</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">
<italic toggle="yes">R</italic>
<sub>meas</sub>
</td><td rowspan="1" colspan="1" align="left" valign="top">0.061 (1.90)</td><td rowspan="1" colspan="1" align="left" valign="top">0.120 (0.47)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">CC<sub>1/2</sub>
</td><td rowspan="1" colspan="1" align="left" valign="top">1.00 (0.37)</td><td rowspan="1" colspan="1" align="left" valign="top">0.998 (0.88)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Overall <italic toggle="yes">B</italic> factor from Wilson plot (&#x000c5;<sup>2</sup>)</td><td rowspan="1" colspan="1" align="left" valign="top">32</td><td rowspan="1" colspan="1" align="left" valign="top">50</td></tr></tbody></table><table-wrap-foot><fn id="tfn5"><label>&#x02020;</label><p>&#x02329;<italic toggle="yes">I</italic>/&#x003c3;(<italic toggle="yes">I</italic>)&#x0232a; falls below 2.0 at 1.67&#x02005;&#x000c5; resolution.</p></fn><fn id="tfn6"><label>&#x02021;</label><p>&#x02329;<italic toggle="yes">I</italic>/&#x003c3;(<italic toggle="yes">I</italic>)&#x0232a; falls below 2.0 at 2.47&#x02005;&#x000c5; resolution.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="table4"><label>Table 4</label><caption><title>Structure solution and refinement</title><p>Values in parentheses are for the outer shell.</p></caption><table frame="hsides" rules="groups"><tbody valign="top"><tr><td rowspan="1" colspan="1" align="left" valign="top">PDB entry </td><td rowspan="1" colspan="1" align="left" valign="top">
<ext-link xlink:href="https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&#x00026;pdbId=6ubl" ext-link-type="uri">6ubl</ext-link>
</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Resolution range (&#x000c5;)</td><td rowspan="1" colspan="1" align="left" valign="top">34.7&#x02013;1.50 (1.52&#x02013;1.50)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Completeness (%)</td><td rowspan="1" colspan="1" align="left" valign="top">97.3</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">No. of reflections, working set</td><td rowspan="1" colspan="1" align="left" valign="top">70715 (2000)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">No. of reflections, test set</td><td rowspan="1" colspan="1" align="left" valign="top">3518 (117)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Final <italic toggle="yes">R</italic>
<sub>work</sub>
</td><td rowspan="1" colspan="1" align="left" valign="top">0.161 (0.405)</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Final <italic toggle="yes">R</italic>
<sub>free</sub>
</td><td rowspan="1" colspan="1" align="left" valign="top">0.185 (0.362)</td></tr><tr><td rowspan="1" colspan="2" align="left" valign="top">No. of non-H atoms</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;Protein</td><td rowspan="1" colspan="1" align="left" valign="top">3287</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;Ligand</td><td rowspan="1" colspan="1" align="left" valign="top">3</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;Solvent</td><td rowspan="1" colspan="1" align="left" valign="top">422</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;Total</td><td rowspan="1" colspan="1" align="left" valign="top">374</td></tr><tr><td rowspan="1" colspan="2" align="left" valign="top">Ligand RSC</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;Palmitic acid A</td><td rowspan="1" colspan="1" align="left" valign="top">0.94</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;Palmitic acid B</td><td rowspan="1" colspan="1" align="left" valign="top">0.91</td></tr><tr><td rowspan="1" colspan="2" align="left" valign="top">R.m.s. deviations</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;Bonds (&#x000c5;)</td><td rowspan="1" colspan="1" align="left" valign="top">0.007</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;Angles (&#x000b0;)</td><td rowspan="1" colspan="1" align="left" valign="top">1.0</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">Average <italic toggle="yes">B</italic> factors (&#x000c5;<sup>2</sup>)</td><td rowspan="1" colspan="1" align="left" valign="top">32</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;Protein</td><td rowspan="1" colspan="1" align="left" valign="top">31</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;Ligand</td><td rowspan="1" colspan="1" align="left" valign="top">46</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;Water</td><td rowspan="1" colspan="1" align="left" valign="top">41</td></tr><tr><td rowspan="1" colspan="2" align="left" valign="top">Ramachandran plot</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;Most favored (%)</td><td rowspan="1" colspan="1" align="left" valign="top">99.3</td></tr><tr><td rowspan="1" colspan="1" align="left" valign="top">&#x02003;Allowed outliers (%)</td><td rowspan="1" colspan="1" align="left" valign="top">0.0</td></tr></tbody></table></table-wrap></floats-group></article>